SpliSense | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8 results for “SpliSense”

Trials

OptiSense™ Performance in Detecting Atrial Episodes

50 participants · First posted Mar 27, 2009

Drugs

exon-splicing antisense oligonucleotide therapeutic (SpliSense)

exon 23 -splicing antisense oligonucleotide therapeutic (SpliSense)

Organizations

SpliSense Ltd.

Israel

News

SpliSense Receives EMA e-PRIME Designation for SPL84 Antisense Therapy in Cystic Fibrosis

SpliSense Achieves First Positive Phase 2 Results for Inhaled Antisense Therapy in Cystic Fibrosis

SpliSense Initiates Phase 2b Trial of Inhaled ASO SPL84 as Add-On to CFTR Modulators in Cystic Fibrosis